X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

UTHR

Closed

United Therapeutics Corporation

345.63
-4.38 (-1.25%)
Last Update: 06 Sep 2024 23:00:00
Yesterday: 350.01
Day's Range: 345.33 - 351.64
Send
When Written:
 
226.3
United Therapeutics Corporation is a biotechnology company that develops and commercializes innovative products to address the unmet medical needs of patients with chronic and life-threatening diseases. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.

United Therapeutics focuses on developing therapies for pulmonary arterial hypertension (PAH), a rare and serious disease that affects the blood vessels in the lungs. The company's flagship product, Remodulin, is an injectable drug that treats PAH by dilating blood vessels and improving blood flow.

In addition to Remodulin, United Therapeutics also markets other products for the treatment of PAH, including Tyvaso, Orenitram, and Adcirca. The company is also developing new therapies for other diseases, such as cancer and organ transplantation.

United Therapeutics has a strong research and development program and has partnerships with other companies and academic institutions to advance its pipeline of products. The company is committed to improving the lives of patients with serious illnesses and is dedicated to advancing the science of medicine.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:3.140.185.190
X